Table 2 SH2B1 expression and clinicopathological features in non-small cell lung cancer (NSCLC) patients

From: MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC

Variables	n	SH2B1 expression
Variables	n	+	++	+++	p value^*
Gender
Male	67	16	16	35
Female	24	3	6	15	0.486
Age(years)
> 55	56	14	10	32
≦55	35	5	12	18	0.156
Smoking history
Yes	54	14	11	29
No	37	5	11	21	0.293
Pathological type
Adenocarcinoma	54	15	12	27
Squamous carcinoma	37	4	10	23	0.063
Tumor differentiation
High	22	7	6	9
Middle	58	10	14	34
Low	11	2	2	7	0.518
Tumor location
Right lung	45	11	10	24
Left lung	46	8	12	26	0.696
Tumor size(cm)
> 3	54	8	12	34
≦3	37	11	10	16	0.129
Lymphatic metastasis
Yes	42	0	10	32
No	49	19	12	18	<0.001
TNM classification
I	43	18	10	15
II	22	1	9	12
III + IV	26	0	3	23	<0.001

Abbreviations: TNM tumor-node-metastasis
^* χ²test

Back to article page